Alpharma Pharms Drug Patent Portfolio
Alpharma Pharms owns 1 orange book drug protected by 9 US patents Given below is the list of Alpharma Pharms's drug patents along with their expiration dates.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8623418 | Pharmaceutical composition | 07 Nov, 2029 | Active |
US7815934 | Sequestering subunit and related compositions and methods | 12 Dec, 2027 | Active |
US7682633 | Pharmaceutical composition | 19 Jun, 2027 | Active |
US7682634 | Pharmaceutical compositions | 19 Jun, 2027 | Active |
US8158156 | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist | 19 Jun, 2027 | Active |
US8846104 | Pharmaceutical compositions for the deterrence and/or prevention of abuse | 19 Jun, 2027 | Active |
US8877247 | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist | 19 Jun, 2027 | Active |
US8685443 | Sequestering subunit and related compositions and methods | 03 Jul, 2025 | Active |
US8685444 | Sequestering subunit and related compositions and methods | 03 Jul, 2025 | Active |
Latest Legal Activities on Alpharma Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Alpharma Pharms.
Activity | Date | Patent Number |
---|---|---|
Expire Patent
Critical
| 20 May, 2024 | US8158156 |
Maintenance Fee Reminder Mailed
Critical
| 04 Dec, 2023 | US8158156 |
Expire Patent
Critical
| 12 Dec, 2022 | US8877247 |
Expire Patent
Critical
| 21 Nov, 2022 | US7815934 (Litigated) |
Expire Patent
Critical
| 07 Nov, 2022 | US8846104 |
Maintenance Fee Reminder Mailed
Critical
| 27 Jun, 2022 | US8877247 |
Maintenance Fee Reminder Mailed
Critical
| 06 Jun, 2022 | US7815934 (Litigated) |
Maintenance Fee Reminder Mailed
Critical
| 23 May, 2022 | US8846104 |
Expire Patent
Critical
| 25 Apr, 2022 | US7682633 (Litigated) |
Expire Patent
Critical
| 25 Apr, 2022 | US7682634 (Litigated) |
Maintenance Fee Reminder Mailed
Critical
| 08 Nov, 2021 | US7682633 (Litigated) |
Maintenance Fee Reminder Mailed
Critical
| 08 Nov, 2021 | US7682634 (Litigated) |
Payment of Maintenance Fee, 8th Year, Large Entity | 16 Sep, 2019 | US8158156 |
Payment of Maintenance Fee, 4th Year, Large Entity | 13 Apr, 2018 | US8877247 |
Payment of Maintenance Fee, 8th Year, Large Entity | 13 Mar, 2018 | US7815934 (Litigated) |
Alpharma Pharms's Family Patents
Alpharma Pharms Drug List
Given below is the complete list of Alpharma Pharms's drugs and the patents protecting them.
1. Embeda
Embeda is protected by 9 patents, out of which none have expired yet. Check out its patent list below.
Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
---|---|---|---|
US8623418 | Pharmaceutical composition |
07 Nov, 2029
(4 years from now)
| Active |
US7815934 | Sequestering subunit and related compositions and methods |
12 Dec, 2027
(2 years from now)
| Active |
US7682633 | Pharmaceutical composition |
19 Jun, 2027
(2 years from now)
| Active |
US7682634 | Pharmaceutical compositions |
19 Jun, 2027
(2 years from now)
| Active |
US8158156 | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist |
19 Jun, 2027
(2 years from now)
| Active |
US8846104 | Pharmaceutical compositions for the deterrence and/or prevention of abuse |
19 Jun, 2027
(2 years from now)
| Active |
US8877247 | Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist |
19 Jun, 2027
(2 years from now)
| Active |
US8685443 | Sequestering subunit and related compositions and methods |
03 Jul, 2025
(6 months from now)
| Active |
US8685444 | Sequestering subunit and related compositions and methods |
03 Jul, 2025
(6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Embeda's drug page